Clinical Trial Update: V-IMMUNE: A Novel Immunoglobulin Therapy for Immunodeficiency [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial evaluating V-IMMUNE, a novel immunoglobulin therapy, for primary immunodeficiencies including agammaglobulinemia; recruitment is ongoin…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Agammaglobulinemia
• Immunodeficiency

Drugs mentioned

• V-IMMUNE

Snippet

Sponsor: On Pharma Importadora, Exportadora e Distribuidora de Medicamentos LTDA. | Conditions: Immunodeficiencies, Primary Immunodeficiencies (PID) | Phase 3 | Status: RECRUITING